Utah’s Attorney General has filed suit against Johnson & Johnson and AstraZeneca for the illegal off-label marketing of anti-psychotic drugs. The suit, filed in a Utah state court last m... Read more
The federal government has reached a $520 million settlement with pharmaceutical manufacturer AstraZeneca. The case dealt with the company’s promotion of off-label uses for the antipsy... Read more
Some antiseizure drugs used to treat epilepsy as well as depression, chronic pain, migraine, bipolar disorder, and other conditions are said to be associated with a higher risk of suicide an... Read more
Federal regulators say that Pfizer has failed to correct problems with its testing procedures that resulted in overdoses for more than two dozen patients during a company trial. The FDA issu... Read more
Neurontin, manufactured by Pfizer subsidiary Parke-Davis, is a medication originally developed for the treatment of epilepsy. It was approved by the FDA in 1994, and in 2002 an indication wa... Read more
Eli Lilly & Co. will pay $62 million to resolve claims relating to the marketing and promotion of its anti-psychotic drug Zyprexa to patients who did not have schizophrenia or bipolar d... Read more
A federal judge in Brooklyn, New York, ruled recently that pension funds, labor unions and insurance companies that bought Eli Lilly & Co’s Zyprexa drug could sue as a group and w... Read more
Documents from a pending lawsuit reveal that Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for sc... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.